Company · ABT
Abbott Laboratories
Name as listed on its exchange; filed with the SEC as ABBOTT LABORATORIES.
Nasdaq's symbol directory lists ABT on the New York Stock Exchange as “Abbott Laboratories Common Stock”.
In the 12 months to Nov 19, 2026: insiders bought on 3 occasions ($1.3M); insiders sold on 4 occasions ($47.3M); 4 planned-sale notices; 38 congressional trade disclosures; 5 company reports (Form 8-K, since May 26, 2026).
All insider filings at the SEC · Appeared in No. 55, No. 33, No. 31
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Robert B. Ford, CHAIRMAN AND CEO sold $46.2M
- Daniel J. Starks bought $927K
- Morrone Louis H., EXECUTIVE VICE PRESIDENT sold $643K
- Moreland Mary K, EXECUTIVE VICE PRESIDENT sold $406K
- Philip P. Boudreau, EVP AND CFO bought $201K
- John G. Stratton bought $174K
- MCCOY JOHN A. JR., VICE PRESIDENT AND CONTROLLER sold $3K
Every trade (7)
- SELLMoreland Mary K, EXECUTIVE VICE PRESIDENT sold $406K
- SELLMCCOY JOHN A. JR., VICE PRESIDENT AND CONTROLLER sold $3K
- SELLRobert B. Ford, CHAIRMAN AND CEO sold $46.2M
- SELLMorrone Louis H., EXECUTIVE VICE PRESIDENT sold $643K
- BUYJohn G. Stratton bought $174K
- BUYDaniel J. Starks bought $927K
- BUYPhilip P. Boudreau, EVP AND CFO bought $201K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- Mary K. Moreland $406K
- John A. McCoy, Jr. $3K
- Robert B. Ford $46.2M
- Louis H. Morrone $643K
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Pete Sessions (R-TX17): Sale $50,001 - $100,000
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
- Thomas H. Kean (R-NJ07): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Richard Dean Dr McCormick (R-GA06): Sale $1,001 - $15,000
- Mike Kelly (R-PA16): Sale $1,001 - $15,000
- Richard W. Allen (R-GA12): Sale $15,001 - $50,000
- Rick Larsen (D-WA02): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
- Richard Dean Dr McCormick (R-GA06): Purchase $1,001 - $15,000
- Richard Dean Dr McCormick (R-GA06): Purchase $1,001 - $15,000
- Josh Gottheimer (D-NJ05): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $15,001 - $50,000
- Gilbert Cisneros (D-CA31): Sale $1,001 - $15,000
- Julie Johnson (D-TX32): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $15,001 - $50,000
- Richard W. Allen (R-GA12): Sale $15,001 - $50,000
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Alan Armstrong (R-OK): Sale (Full) $15,001 - $50,000
- Laura Friedman (D-CA30): Exchange $1,001 - $15,000
- Richard Dean Dr McCormick (R-GA06): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Michael T. McCaul (R-TX10): Sale $1,001 - $15,000
- Michael T. McCaul (R-TX10): Sale $15,001 - $50,000
- Gilbert Cisneros (D-CA31): Sale $1,001 - $15,000
- Thomas H. Kean (R-NJ07): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $15,001 - $50,000
- Rohit Khanna (D-CA17): Sale $15,001 - $50,000
- Rohit Khanna (D-CA17): Sale $15,001 - $50,000
- Gilbert Cisneros (D-CA31): Sale $1,001 - $15,000
- Julie Johnson (D-TX32): Sale $1,001 - $15,000
- Julia Letlow (R-LA05): Sale $1,001 - $15,000
- Byron Donalds (R-FL19): Sale $1,001 - $15,000
- Byron Donalds (R-FL19): Sale $1,001 - $15,000
Executive branch · OGE Form 278-T
Reported by the President
3 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports
- Purchase: ABBOTT LABORATORIES $100,001 – $250,000
- Sale: ABBOTT LABORATORIES $100,001 – $250,000
- Sale: ABBOTT LABORATORIES $50,001 – $100,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Departure or appointment of directors or officers Nov 16, 2026
- Results of operations and financial condition Oct 21, 2026
- Other events Oct 21, 2026
- Regulation FD disclosure; Other events Aug 20, 2026
- Results of operations and financial condition Jul 16, 2026
Lobbying · Senate LDA reports
Lobbying filed
35 quarterly lobbying reports for 2026 naming Abbott Laboratories as the client: 4 filed by the company itself, 31 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.
- The company itself $1.3M
- AKIN GUMP STRAUSS HAUER & FELD $60K
- MARSHALL & POPP, LLC $60K
- S-3 GROUP $60K
- KOUNTOUPES DENHAM CARR & REID, LLC $60K
- PHRONESISDC, LLC $50K
- W STRATEGIES, LLC $50K
- TIBER CREEK GROUP $50K
- DUDDINGTON GLOBAL STRATEGIES LLC $10K
- THE DUBERSTEIN GROUP INC. no amount stated
- THE DUBERSTEIN GROUP INC. no amount stated
- FEDERAL HEALTH POLICY STRATEGIES no amount stated
- MAYER BROWN LLP no amount stated
- DUDDINGTON GLOBAL STRATEGIES LLC no amount stated
- The company itself $1.1M
- S-3 GROUP $60K
- AKIN GUMP STRAUSS HAUER & FELD $60K
- MARSHALL & POPP, LLC $60K
- KOUNTOUPES DENHAM CARR & REID, LLC $60K
- PHRONESISDC, LLC $50K
- TIBER CREEK GROUP $50K
- W STRATEGIES, LLC $50K
- FEDERAL HEALTH POLICY STRATEGIES no amount stated
- PHRONESISDC, LLC no amount stated
- MAYER BROWN LLP no amount stated
Showing 25 of 35.
Federal contracts · USAspending.gov
Federal contracts
86 contract awards first obligated in the last 12 months to the company or a subsidiary it lists in its 10-K, $18.1M in total obligated as USAspending.gov lists each award when Lytir last read it. Largest first.
- Department of Veterans Affairs $3.4M
- Department of Veterans Affairs $1.8M
- Department of Veterans Affairs $1.5M
- Department of Veterans Affairs $1.5M
- Department of Veterans Affairs $1.3M
- Department of Veterans Affairs $1.2M
- Department of Veterans Affairs $895K
- Department of Veterans Affairs $790K
- Department of Veterans Affairs $784K
- Department of Veterans Affairs $608K
- Department of Veterans Affairs $432K
- Department of Veterans Affairs $395K
- Department of Veterans Affairs $313K
- Department of Veterans Affairs $290K
- Department of Veterans Affairs $268K
- Department of Veterans Affairs $245K
- Department of Veterans Affairs $212K
- Department of Veterans Affairs $188K
- Department of Veterans Affairs $159K
- Department of Veterans Affairs $146K
- Department of Veterans Affairs $136K
- Department of Veterans Affairs $132K
- Department of Veterans Affairs $129K
- Department of Veterans Affairs $120K
- Department of Veterans Affairs $120K
Showing the 25 largest of 86.
Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, USAspending.gov, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.